Novartis
NVS
#52
Rank
$205.53 B
Marketcap
๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Country
$91.89
Share price
0.62%
Change (1 day)
3.77%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Revenue for Novartis (NVS)

Revenue in 2021 (TTM): $50.39 B

According to Novartis's latest financial reports the company's current revenue (TTM) is $50.39 B. In 2020 the company made a revenue of $48.65 B an increase over the years 2019 revenue that were of $47.49 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expences are substracted.

Revenue history for Novartis from 2001 to 2021

Year Revenue Change
2021 (TTM)$50.39 B3.57%
2020$48.65 B2.44%
2019$47.49 B-5.32%
2018$50.16 B2.15%
2017$49.10 B1.22%
2016$48.51 B-1.86%
2015$49.44 B-7.78%
2014$53.60 B-7.44%
2013$57.92 B2.63%
2012$56.43 B-4.95%
2011$59.37 B15.15%
2010$51.56 B14.82%
2009$44.90 B7.52%
2008$41.76 B6.53%
2007$39.20 B9.6%
2006$35.77 B11.31%
2005$32.13 B13.78%
2004$28.24 B13.61%
2003$24.86 B6.62%
2002$23.32 B19.8%
2001$19.46 B